How Far Do Research Priority Setting Exercises Influence What Research Is Undertaken: A Little, a Lot, or Not at All?
Author:
- 1 March 2019
- journal article
- editorial
- Published by Wolters Kluwer Health in Cancer Nursing
- Vol. 42 (2) , 89-90
Abstract
Readers of this journal are well placed to reflect on the highs and lows of receiving grant funding. I am recalling a respected pediatric oncologist offering me encouraging words when in the midst of a grant application, saying, “You stand a better chance of getting a grant when you submit to the call than if you didn’t!” Disappointment or success is not my focus here. Rather, my focus is on how research priorities described by healthcare professionals, with and without the inclusion of the voice of their respective patient groups, influence research undertaken in our various cancer populations. Iain Chalmers,1 a UK health services researcher, a founder of the Cochrane Collaboration, famously challenged researchers in 1995 (p1318) by stating, “Greater lay involvement in setting the research agenda would almost certainly lead to greater open mindedness about which questions are worth addressing.” He went further with others in 2005, to suggest that there was indeed a mismatch, where “the uncertainities rated important by clinicians and patients are often not those being addressed in research.”2(p232) He worked with like-minded individuals to address this mismatch through the development in 2004 of the James Lind Alliance (JLA) research Priority Setting Partnerships (PSPs).3 These partnerships are where patients, carers, and healthcare professionals come together and, using a systematic approach, develop, and agree on shared priorities for research, questions important to a particular health condition, a treatment uncertainty, or, in our case, a patient population (http://www.jla.nihr.ac.uk/priority-setting-partnerships/teenage-and-young-adult-cancer/). There are currently 99 PSPs listed on the JLA website, of which 12 are cancer related (http://www.jla.nihr.ac.uk/priority-setting-partnerships/). The outputs from these partnerships are made widely available to researchers and funders, and yet in 2015, Crowe and colleagues,4 reporting on a comparison between treatment research priorities identified by patients, carers, and clinicians with research actually done by researchers, revealed the mismatch still exists. Their added point was “the current research ‘system,’ and culture is not geared to bridging the mismatch.”4(p9) So, what can be done? Why does this mismatch continue to exist? I would argue that the burden for reducing this mismatch cannot rest solely on the various PSPs that have in many cases successfully engaged with their communities to share these priorities. Although some have had success with commissioning research reflecting the priorities identified (http://www.jla.nihr.ac.uk/priority-setting-partnerships/palliative-and-end-of-life-care/downloads/December2015-newsletter.pdf), others have been less successful. I am not alone in allocating some of this responsibility to researchers and to funders of research. This led me to ask 2 questions: (1) How far are the priorities of PSPs reflected in the research portfolio of the relevant funding bodies? (2) How far are researchers influenced by the priorities from PSPs? On reflection, I think the two are closely connected. To answer the why question, we may have to return to the prevailing culture of research, where greater status and funding are still awarded by some to “basic research” as opposed to “applied research”; where what Ioannidis5 refers to as “blue sky science” is prioritized by funders and researchers. We may have to acknowledge that the patient voice and responding to questions about what is important to our patients might not be valued by everyone associated with research in our respective fields, despite the heightened interest in patient-centered research.6 There may even be a shared bias toward funding “basic research”: who would not want to fund research that may find a cure for cancer or prevent more persons from developing cancer? Alone or combined, these might be some of the reasons why the mismatch occurs.Keywords
This publication has 8 references indexed in Scilit:
- Why Most Clinical Research Is Not UsefulPLOS Medicine, 2016
- Erratum to: Patients’, clinicians’ and the research communities’ priorities for treatment research: there is an important mismatchResearch Involvement and Engagement, 2015
- Patient-Centeredness in the Design of Clinical TrialsValue in Health, 2014
- PCORI at 3 Years — Progress, Lessons, and PlansNew England Journal of Medicine, 2014
- Tackling treatment uncertainties together: the evolution of the James LindInitiative, 2003–2013Journal of the Royal Society of Medicine, 2013
- How The Patient-Centered Outcomes Research Institute Is Engaging Patients And Others In Shaping Its Research AgendaHealth Affairs, 2013
- Is the NHS willing to help clinicians and patients reduce uncertainties about the effects of treatments?Clinical Medicine, 2005
- What do I want from health research and researchers when I am a patient?BMJ, 1995